Charles River Laboratories Announces First-Quarter 2021 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St set for higher open but weekly losses loom
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Supermicro probe finds no senior management link to export violations
- SpaceX shares fall as second lockup period ends
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Charles River Laboratories (CRL) Tops Q1 EPS by 34c; Raises Outlook
May 4, 2021 7:02 AM EDTCharles River Laboratories (NYSE: CRL) reported Q1 EPS of $2.53, $0.34 better than the analyst estimate of $2.19. Revenue for the quarter came in at $824.6 million versus the consensus estimate of $798.53 million.
James C. Foster, Chairman, President and Chief Executive Officer, said, Our first-quarter performance demonstrates the... More
